$HUDI

Huadi International Group Co., Ltd. (HUDI) Company Information

This article provides key company information for Huadi International Group Co., Ltd. (HUDI), including its ticker, exchange, founding year, industry, sector, market cap, shares outstanding, and location. It details the data sources and methodology used by Simply Wall St for its analysis, emphasizing the comprehensive financial and market data incorporated for report generation. The document also mentions where to find more information about their analysis model and financial data updates.

Original reporting
Published Mar 15, 2026, 2:51 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 15, 2026, 3:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$HUDI
Neutral
medium confidence
Mentioned
$HUDI
alphai data visualization · based on Simply Wall St
Decision brief

The 30-second read

$HUDINeutralLow
01

Why it matters

Current data suggests stability; no significant news events impacting stock price in the near term.

02

Market read

The news provides detailed company fundamentals but has limited immediate trading relevance due to neutral sentiment and lack of catalysts.

03

What to watch

Possible upcoming earnings reports or industry developments could alter the outlook; macroeconomic factors affecting manufacturing sector should be monitored.

Timing: low

Background

Huadi International Group is a Chinese manufacturer specializing in metal products, with a focus on quality and export markets.

Company-level read

Ticker impact

$HUDINeutralMedium confidence
Context

The article provides comprehensive company information for Huadi International Group Co., Ltd. (HUDI), including its financial metrics and industry positioning.

Expected impact

Minimal short-term price movement expected; long-term impact uncertain due to limited recent developments.

Evidence & confidence

The sentiment is neutral, and the data is descriptive without indicating any immediate catalysts or risks, leading to a cautious outlook.

Market effects

The manufacturing sector may experience stable conditions; no significant sector-wide shifts indicated.

Limited regional impact; company operates primarily in China with minimal influence on regional markets.

Low; company is a niche manufacturer with limited global market influence.

Counterpoint

Potential for undervaluation if company fundamentals improve; long-term investors might consider accumulation on dips.

Key entities

  • Huadi International Group Co., Ltd.

    A Chinese manufacturer in the materials sector, focusing on metal products.

  • Manufacturing Industry

    Industry sector involving production of metal and related products.

Related articles

$TRGPMed

Targa Resources Stock Gains 7%

Targa Resources Corp. (TRGP) shares rose 7% to $297.68 after announcing 20-year agreements with ExxonMobil (XOM) subsidiaries for natural gas services in the Permian Basin. The stock's 52-week range is $144.14 to $305.08.

$XYLMed

Why is Xylem stock sliding today?

Xylem shares fell about 3.4% after the company said CFO William “Bill” Grogan will leave to become CFO at GE HealthCare, effective Sept. 1, 2026, with Andrea van der Berg named successor. Xylem reaffirmed its Q3 and full-year 2026 guidance. The move came as Nasdaq and industrial stocks were pressured by higher Treasury yields and rising oil prices.

$BETRMed

CEO Who Allegedly Called Staff ‘Monkeys’ Is Being Sued By His Company

Better Home & Finance sued its founder and former CEO Vishal Garg, alleging he led a “scorched-earth campaign” to regain control. The dispute follows claims during his tenure that he called employees “monkeys” and “dumb dolphins.” Better Home says Garg was reinstalled as CEO in 2022 after a 2021 mass layoff. The lender has processed over $110B in loans.

$NFLXMed

Netflix Climbs 4% on Ackman’s Return, Still Down 16% in 2026

Bill Ackman’s Pershing Square disclosed a new position in Netflix (NFLX), lifting the stock about 4% to $78.80 in Tuesday trading. The move followed a prior 2022 Netflix stake that ended in a loss. Disney (DIS) and Warner Bros. Discovery (WBD) rose less than 1%, suggesting a Netflix-specific catalyst. Netflix trades at 28.83x trailing P/E and is down 16% YTD.

$BIIBMed

Eyes on Asia: Tanabe Pharma, KYAN Technologies, Biogen

LEO Pharma agreed to acquire worldwide rights to Tanabe Pharma’s dersimelagon for up to $435m. The late-stage oral drug completed Phase III, with an FDA NDA filed June 2026. Thermo Fisher and KYAN Technologies will collaborate on precision oncology using patient-derived tumoroids. Biogen’s felzartamab won China NMPA approval for multiple myeloma. Expedition Therapeutics raised $115m Series B for EXPD-101 COPD Phase II.